-
E.
Moran,
B
Brandt,
W.
Zollinger
(1994)
Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity
Infection and Immunity, 62
-
V.
Pinto,
E.
Moran,
F.
Cruz,
Xin-Ming
Wang,
A.
Fridman,
W.
Zollinger,
C.
Przysiecki,
R.
Burden
(2011)
An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups.
Vaccine, 29 44
-
O.
Westphal
(1965)
Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure
, 5
-
G.
Norheim,
A.
Aseffa,
M.
Yassin,
G.
Mengistu,
A.
Kassu,
D.
Fikremariam,
Wegene
Tamire,
Y.
Merid,
E.
Høiby,
D.
Caugant,
Elisabeth
Fritzsønn,
T.
Tangen,
Berhanu
Melak,
D.
Berhanu,
M.
Harboe,
J.
Kolberg,
E.
Rosenqvist
(2008)
Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A Meningococci
Clinical and Vaccine Immunology, 15
-
M.
Comanducci,
S.
Bambini,
B.
Brunelli,
J.
Adu‐Bobie,
B.
Aricó,
B.
Capecchi,
M.
Giuliani,
V.
Masignani,
L.
Santini,
S.
Savino,
D.
Granoff,
D.
Caugant,
M.
Pizza,
R.
Rappuoli,
Marirosa
Mora
(2002)
NadA, a Novel Vaccine Candidate of Neisseria meningitidis
The Journal of Experimental Medicine, 195
-
Ivo
Claassen,
J.
Meylis,
P.
Ley,
CarlaC.A.M.
Peeters,
Hans
Brons,
Jolanda
Robert,
Dominique
Borsboom,
Arno
Ark,
Ineke
Straaten,
Paul
Roholl,
B.
Kuipers,
J.
Poolman
(1996)
Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine.
Vaccine, 14 10
-
W.
Zollinger,
E.
Moran,
D.
Schmiel
(2009)
Characterization of an Antibody Depletion Assay for Analysis of Bactericidal Antibody Specificity
Clinical and Vaccine Immunology, 16
-
J.
Armand,
F.
Arminjon,
M.
Mynard,
C.
Lafaix
(1982)
Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation.
Journal of biological standardization, 10 4
-
G.
Norheim,
E.
Rosenqvist,
A.
Aseffa,
M.
Yassin,
G.
Mengistu,
A.
Kassu,
D.
Fikremariam,
Wegene
Tamire,
E.
Høiby,
Tsegaye
Alebel,
D.
Berhanu,
Yarid
Merid,
M.
Harboe,
D.
Caugant
(2006)
Characterization of Neisseria meningitidis Isolates from Recent Outbreaks in Ethiopia and Comparison with Those Recovered during the Epidemic of 1988 to 1989
Journal of Clinical Microbiology, 44
-
V.
Masignani,
M.
Comanducci,
M.
Giuliani,
S.
Bambini,
J.
Adu‐Bobie,
B.
Aricó,
B.
Brunelli,
A.
Pieri,
L.
Santini,
S.
Savino,
D.
Serruto,
D.
Litt,
S.
Kroll,
J.
Welsch,
D.
Granoff,
R.
Rappuoli,
M.
Pizza
(2003)
Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
The Journal of Experimental Medicine, 197
-
P.
Boisier,
P.
Nicolas,
S.
Djibo,
M.
Taha,
I.
Jeanne,
H.
Maïnassara,
B.
Tenebray,
Kiari
Kairo,
D.
Giorgini,
S.
Chanteau
(2007)
Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44 5
-
Andrew
Rowan
(1996)
Guide for the Care and Use of Laboratory Animals
Journal of Medical Primatology, 8
-
D.
Mutonga,
G.
Pimentel,
J.
Muindi,
C.
Nzioka,
J.
Mutiso,
J.
Klena,
M.
Morcos,
T.
Ogaro,
S.
Materu,
C.
Tetteh,
Nancy
Messonnier,
R.
Breiman,
D.
Feikin
(2009)
Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006.
The American journal of tropical medicine and hygiene, 80 4
-
P.
Bonvehi,
D.
Boutriau,
J.
Casellas,
V.
Weynants,
C.
Feron,
J.
Poolman
(2010)
Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults
Clinical and Vaccine Immunology, 17
-
(2008)
Specificity of the sub-capsular antibody responses following serogroup A meningococcal disease in Ethiopian patients
-
Isabelle
Delrieu,
S.
Yaro,
T.
Tamekloe,
B.
Njanpop-Lafourcade,
H.
Tall,
P.
Jaillard,
M.
Ouédraogo,
Kossi
Badziklou,
O.
Sanou,
A.
Drabo,
B.
Gessner,
J.
Kambou,
J.
Mueller
(2011)
Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
PLoS ONE, 6
-
K.
Reisinger,
R.
Baxter,
S.
Block,
J.
Shah,
L.
Bedell,
P.
Dull
(2009)
Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
Clinical and Vaccine Immunology, 16
-
E.
Gotschlich,
Teh-Yung.
Liu,
M.
Artenstein
(1969)
HUMAN IMMUNITY TO THE MENINGOCOCCUS
The Journal of Experimental Medicine, 129
-
Patricia
Martin,
K.
Makepeace,
S.
Hill,
D.
Hood,
E.
Moxon
(2005)
Microsatellite instability regulates transcription factor binding and gene expression.
Proceedings of the National Academy of Sciences of the United States of America, 102 10
-
M.
Bröker,
P.
Dull,
R.
Rappuoli,
P.
Costantino
(2009)
Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages.
Vaccine, 27 41
-
Westphal
(1965)
Bacterial lipopolysaccharides
Extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem., 5
-
(2003)
HUMAN IMMUNITY TO THE MENINGOCOCCUS
-
Kedibone
Mothibeli,
M.
Plessis,
A.
Gottberg,
E.
Murphy,
S.
Hoiseth,
G.
Zlotnick,
K.
Klugman
(2011)
Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.
Vaccine, 29 11
-
Oliver
Koeberling,
I.
Delany,
D.
Granoff
(2011)
A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines
Clinical and Vaccine Immunology, 18
-
P.
Keiser,
S.
Biggs-Cicatelli,
E.
Moran,
Deborah
Schmiel,
V.
Pinto,
Robert
Burden,
Lori
Miller,
James
Moon,
Robert
Bowden,
J.
Cummings,
W.
Zollinger
(2011)
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.
Vaccine, 29 7
-
J.
Findlow,
R.
Borrow,
M.
Snape,
T.
Dawson,
A.
Holland,
T.
John,
A.
Evans,
K.
Telford,
E.
Ypma,
D.
Toneatto,
P.
Oster,
E.
Miller,
A.
Pollard
(2010)
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 51 10
-
W.
Zollinger,
M.
Donets,
D.
Schmiel,
V.
Pinto,
Joseph
Labrie,
E.
Moran,
B.
Brandt,
B.
Ionin,
Ryan
Marques,
Max
Wu,
Ping
Chen,
M.
Stoddard,
P.
Keiser
(2010)
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.
Vaccine, 28 31
-
M.
Fisseha,
Ping
Chen,
B.
Brandt,
Todd
Kijek,
E.
Moran,
W.
Zollinger
(2005)
Characterization of Native Outer Membrane Vesicles from lpxL Mutant Strains of Neisseria meningitidis for Use in Parenteral Vaccination
Infection and Immunity, 73
-
Sebastián
Real,
Nathalie
Meo-Evoli,
Lília
Espada,
A.
Tauler
(2011)
E2F1 Regulates Cellular Growth by mTORC1 Signaling
PLoS ONE, 6
-
J.
Mueller,
L.
Sangaré,
B.
Njanpop-Lafourcade,
Z.
Tarnagda,
Y.
Traoré,
S.
Yaro,
Raymond
Borrow,
B.
Gessner,
P.
Nicolas
(2007)
Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003
Emerging Infectious Diseases, 13
-
P.
Polyakov,
C.
Soussen,
Junbo
Duan,
J.
Duval,
D.
Brie,
G.
Francius
(2011)
Automated Force Volume Image Processing for Biological Samples
PLoS ONE, 6
-
P.
Beernink,
D.
Caugant,
J.
Welsch,
Oliver
Koeberling,
D.
Granoff
(2009)
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.
The Journal of infectious diseases, 199 9
-
M.
Giuliani,
J.
Adu‐Bobie,
M.
Comanducci,
B.
Aricó,
S.
Savino,
L.
Santini,
B.
Brunelli,
S.
Bambini,
A.
Biolchi,
B.
Capecchi,
E.
Cartocci,
L.
Ciucchi,
Federica
Marcello,
Francesca
Ferlicca,
B.
Galli,
E.
Luzzi,
V.
Masignani,
D.
Serruto,
D.
Veggi,
M.
Contorni,
M.
Morandi,
A.
Bartalesi,
V.
Cinotti,
D.
Mannucci,
F.
Titta,
E.
Ovidi,
J.
Welsch,
D.
Granoff,
R.
Rappuoli,
M.
Pizza
(2006)
A universal vaccine for serogroup B meningococcus.
Proceedings of the National Academy of Sciences of the United States of America, 103 29
-
M.
Maiden,
J.
Bygraves,
E.
Feil,
G.
Morelli,
J.
Russell,
R.
Urwin,
Qing
Zhang,
Jiaji
Zhou,
Kerstin
Zurth,
D.
Caugant,
I.
Feavers,
M.
Achtman,
B.
Spratt
(1998)
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.
Proceedings of the National Academy of Sciences of the United States of America, 95 6
-
Subramonia
Pillai,
Alan
Howell,
Kristin
Alexander,
B.
Bentley,
Han-Qian
Jiang,
K.
Ambrose,
Duzhang
Zhu,
G.
Zlotnick
(2005)
Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
Vaccine, 23 17-18
-
(2004)
From HexaMen to NonaMen: expanding a multivalent PorA-based meningococcal outer membrane vesicle vaccine, p 153
-
(2003)
Vaccine against Gram negative bacteria
-
Vincent
Weynants,
P.
Denoel,
Nathalie
Devos,
D.
Janssens,
Christiane
Feron,
Karine
Goraj,
Patricia
Momin,
D.
Monnom,
C.
Tans,
Annick
Vandercammen,
Florence
Wauters,
J.
Poolman
(2009)
Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response
Infection and Immunity, 77
-
J.
Finne,
M.
Leinonen,
P.
Mäkelä
(1983)
ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS Implications for Vaccine Development and Pathogenesis
The Lancet, 322